RaySearch Laboratories: Q1 – Initial take, setting up for more records - Redeye
Bildkälla: Stockfoto

RaySearch Laboratories: Q1 – Initial take, setting up for more records - Redeye

Redeye notes an exceptionally strong Q1 with record sales. RaySearch beat our forecasts on both sales and EBIT, and adjusting for exchange-rate losses, the EBIT margin amounts to a strong 29% – 3%-points above its 2026 target. We remain confident in our assumption of an expected international institutional inflow in the near to medium term, to help push the share to our base case, which we are prone to notch up slightly following the report. We expect the share to trade up 4-6% during the day.

Redeye notes an exceptionally strong Q1 with record sales. RaySearch beat our forecasts on both sales and EBIT, and adjusting for exchange-rate losses, the EBIT margin amounts to a strong 29% – 3%-points above its 2026 target. We remain confident in our assumption of an expected international institutional inflow in the near to medium term, to help push the share to our base case, which we are prone to notch up slightly following the report. We expect the share to trade up 4-6% during the day.
Börsvärldens nyhetsbrev